Serial changes in patient-report BOS symptoms. (A) Trajectory of LSS lung subscale scores over time. (B) Trajectory of LSS lung subscale scores stratified by best response to ruxolitinib (R vs NR, according to NIH criteria). NR, nonresponder; R, responder.